Star Combo Pharma Ltd - Asset Resilience Ratio
Star Combo Pharma Ltd (S66) has an Asset Resilience Ratio of 30.02% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check S66 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Star Combo Pharma Ltd's Asset Resilience Ratio has changed over time. See S66 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Star Combo Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see S66 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$14.10 Million | 30.02% |
| Total Liquid Assets | AU$14.10 Million | 30.02% |
Asset Resilience Insights
- Very High Liquidity: Star Combo Pharma Ltd maintains exceptional liquid asset reserves at 30.02% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Star Combo Pharma Ltd Industry Peers by Asset Resilience Ratio
Compare Star Combo Pharma Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Henkel AG & Co. KGaA vz. (Pref Shares)
XETRA:HEN3 |
Household & Personal Products | 10.45% |
|
Colgate Palmolive (India) Limited
NSE:COLPAL |
Household & Personal Products | 49.03% |
|
ELF Beauty Inc
NYSE:ELF |
Household & Personal Products | 8.47% |
|
Chongqing Baiya Sanitary Products Co
SHE:003006 |
Household & Personal Products | 9.52% |
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009 |
Household & Personal Products | 8.39% |
|
Liuzhou Liangmianzhen Co Ltd
SHG:600249 |
Household & Personal Products | 9.12% |
|
Kolmar Holding
KO:024720 |
Household & Personal Products | 4.87% |
|
KPS Corporation
KQ:256940 |
Household & Personal Products | 2.90% |
Annual Asset Resilience Ratio for Star Combo Pharma Ltd (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Star Combo Pharma Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 29.97% | AU$14.52 Million ≈ $10.27 Million |
AU$48.45 Million ≈ $34.28 Million |
+17.84pp |
| 2024-06-30 | 12.13% | AU$5.20 Million ≈ $3.68 Million |
AU$42.82 Million ≈ $30.29 Million |
-18.65pp |
| 2023-06-30 | 30.79% | AU$13.00 Million ≈ $9.20 Million |
AU$42.23 Million ≈ $29.88 Million |
+3.16pp |
| 2022-06-30 | 27.62% | AU$12.00 Million ≈ $8.49 Million |
AU$43.44 Million ≈ $30.74 Million |
-23.44pp |
| 2021-06-30 | 51.06% | AU$22.12 Million ≈ $15.65 Million |
AU$43.32 Million ≈ $30.65 Million |
+14.51pp |
| 2020-06-30 | 36.55% | AU$20.00 Million ≈ $14.15 Million |
AU$54.72 Million ≈ $38.72 Million |
+32.91pp |
| 2019-06-30 | 3.64% | AU$1.00 Million ≈ $709.00K |
AU$27.51 Million ≈ $19.46 Million |
-- |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more